FLASH NEWS LIVE

Bharat Biotech mulls IPO to raise over USD 500 million

Bharat Biotech mulls IPO to raise over USD 500 million

Bharat Biotech plans Rs 200–250 crore of capital expenditure in FY26 for a large vaccine manufacturing facility being developed under Sapigen Biologix Pvt Ltd in Bhubaneswar, Odisha, partly financed through debt raised from financial institutions.

Read Full Article →

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.
Instagram Meta X LinkedIn Whatsapp